Coronavirus – Cameroon: The Provision of COVID-19 vaccines to the Republic of Cameroon through the COVAX facility

Solomon Whitaker
Published

The Government of Japan has decided to provide approximately 70,000 doses of COVID-19 vaccines manufactured in Japan, through the COVAX facility, as part of assistance by Japan in order to contribute to the prevention of the spread of COVID-19 in Cameroon. These vaccines will be airlifted from Japan to Cameroon on March 19.

These vaccines are expected to contribute to the prevention of the spread of COVID-19 in Cameroon. Japan will continue to provide various assistance in cooperation with relevant countries and international organizations towards the earliest convergence of COVID-19.

(Reference)COVID-19 situation in Cameroon

As of March 17, approximately 200,000 confirmed cases and approximately 2,000 deaths have been reported. Approximately 820,000 doses of vaccine have been administrated, and only about 6 percent of the population has completed the vaccinations.

 

Spread the News. Share on
Facebook Twitter Reddit LinkedIn
Solomon Whitaker profile photo

About Solomon Whitaker

Solomon Whitaker is a journalist and writer at TDPel Media, covering international news, politics, business, and major developments from around the world. He focuses on delivering clear, informative reports that keep readers updated on significant events and emerging stories.